It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An increased incidence of thyroid cancer has been reported in the area close to Mount Etna, the largest volcano in Europe located in Northeastern Sicily. We tested the hypothesis that exposure to the emissions from the volcano is associated with thyroid cancer in 186 municipalities from three provinces surrounding the volcano (1.9 million inhabitants). We measured the angle between the bearing of the municipalities and each direction, with special focus on South-East, the prevalent direction of the plume, and conducted a regression analysis on 2003–2016 incidence rates of thyroid cancer, adjusting for distance from Mount Etna, population size, and income. A 10-degree increase in the angle with South-East was associated with a decrease in thyroid cancer rates in the whole population (− 0.67 cases/100,000, p = 0.002) and in women (− 1.54/100,000, p < 0.001), and were robust to several sensitivity analyses. Similar results were obtained for East-South-East direction. These results support the hypothesis of a potential role of exposure to the plume from Mount Etna in determining the high rates of thyroid cancer. The results need to be confirmed in analytical studies, in which information of exposure to chemicals originating from the volcano, as well as other possible causes, should be carefully measured, molecular characteristics of the tumors and taken into account.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Stony Brook University, Stony Brook Cancer Center and Department of Family, Population and Preventive Medicine, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681); University of Bologna, Department of Medical and Surgical Sciences, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
2 Istituto Oncologico del Mediterraneo, Department of Experimental Oncology, Viagrande, Italy (GRID:grid.6292.f)
3 University of Catania, Department of Medical, Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, Catania, Italy (GRID:grid.8158.4) (ISNI:0000 0004 1757 1969)
4 Istituto Oncologico del Mediterraneo, Department of Experimental Oncology, Viagrande, Italy (GRID:grid.8158.4)